Literature DB >> 33615947

Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Alessio Nocentini1, Andrea Angeli1, Fabrizio Carta1, Jean-Yves Winum2, Raivis Zalubovskis3,4, Simone Carradori5, Clemente Capasso6, William A Donald7, Claudiu T Supuran1.   

Abstract

Inorganic anions inhibit the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) generally by coordinating to the active site metal ion. Cyanate was reported as a non-coordinating CA inhibitor but those erroneous results were subsequently corrected by another group. We review the anion CA inhibitors (CAIs) in the more general context of drug design studies and the discovery of a large number of inhibitor classes and inhibition mechanisms, including zinc binders (sulphonamides and isosteres, dithiocabamates and isosteres, thiols, selenols, benzoxaboroles, ninhydrins, etc.); inhibitors anchoring to the zinc-coordinated water molecule (phenols, polyamines, sulfocoumarins, thioxocoumarins, catechols); CAIs occluding the entrance to the active site (coumarins and derivatives, lacosamide), as well as compounds that bind outside the active site. All these new chemotypes integrated with a general procedure for obtaining isoform-selective compounds (the tail approach) has resulted, through the guidance of rigorous X-ray crystallography experiments, in the development of highly selective CAIs for all human CA isoforms with many pharmacological applications.

Entities:  

Keywords:  carbonic anhydrase; cyanate; inhibition mechanisms; inhibitor; sulphonamide

Mesh:

Substances:

Year:  2021        PMID: 33615947      PMCID: PMC7901698          DOI: 10.1080/14756366.2021.1882453

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  244 in total

1.  Carbonic anhydrase. Purification and nature of the enzyme.

Authors:  D Keilin; T Mann
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

Review 2.  Acetazolamide for the treatment of idiopathic intracranial hypertension.

Authors:  Claudiu T Supuran
Journal:  Expert Rev Neurother       Date:  2015-07-07       Impact factor: 4.618

3.  Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.

Authors:  Claudia Temperini; Andrea Scozzafava; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2009-11-27       Impact factor: 2.823

4.  Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.

Authors:  Carrie L Lomelino; Brian P Mahon; Robert McKenna; Fabrizio Carta; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2016-01-11       Impact factor: 3.641

5.  Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).

Authors:  Alessio Innocenti; Daniela Vullo; Andrea Scozzafava; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2008-01-26       Impact factor: 2.823

6.  Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.

Authors:  Wagdy M Eldehna; Mohamed Fares; Mariangela Ceruso; Hazem A Ghabbour; Sahar M Abou-Seri; Hatem A Abdel-Aziz; Dalal A Abou El Ella; Claudiu T Supuran
Journal:  Eur J Med Chem       Date:  2016-01-20       Impact factor: 6.514

7.  Glycolysis, via NADH-dependent dimerisation of CtBPs, regulates hypoxia-induced expression of CAIX and stem-like breast cancer cell survival.

Authors:  Mira Kreuzer; Arindam Banerjee; Charles N Birts; Matthew Darley; Ali Tavassoli; Mircea Ivan; Jeremy P Blaydes
Journal:  FEBS Lett       Date:  2020-07-15       Impact factor: 4.124

Review 8.  Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.

Authors:  Paul C McDonald; Jean-Yves Winum; Claudiu T Supuran; Shoukat Dedhar
Journal:  Oncotarget       Date:  2012-01

9.  Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms.

Authors:  Alessio Nocentini; Alessandro Bonardi; Paola Gratteri; Bruno Cerra; Antimo Gioiello; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 10.  Coumarin carbonic anhydrase inhibitors from natural sources.

Authors:  Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more
  25 in total

1.  Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII.

Authors:  Simone Giovannuzzi; Clemente Capasso; Alessio Nocentini; Claudiu T Supuran
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

2.  Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris.

Authors:  Ashok Aspatwar; Harlan Barker; Heidi Aisala; Ksenia Zueva; Marianne Kuuslahti; Martti Tolvanen; Craig R Primmer; Jaakko Lumme; Alessandro Bonardi; Amit Tripathi; Seppo Parkkila; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 3.  Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Somdutt Mujwar; Mariusz Mojzych; Beata Marciniak; Rafał Drozda; Renata Kontek
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae.

Authors:  Alessio Nocentini; Chad S Hewitt; Margaret D Mastrolorenzo; Daniel P Flaherty; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii.

Authors:  Viviana De Luca; Andrea Petreni; Vincenzo Carginale; Andrea Scaloni; Claudiu T Supuran; Clemente Capasso
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.

Authors:  Ebru Temiz; Ismail Koyuncu; Mustafa Durgun; Murat Caglayan; Ataman Gonel; Eray Metin Güler; Abdurrahim Kocyigit; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

7.  Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms.

Authors:  Simone Giovannuzzi; Mario D'Ambrosio; Cristina Luceri; Sameh Mohamed Osman; Marco Pallecchi; Gianluca Bartolucci; Alessio Nocentini; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

Review 8.  Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents.

Authors:  Irene Bulli; Ilaria Dettori; Elisabetta Coppi; Federica Cherchi; Martina Venturini; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Alessio Nocentini; Claudiu T Supuran; Anna Maria Pugliese; Felicita Pedata
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

9.  Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.

Authors:  Andrea Angeli; Victor Kartsev; Anthi Petrou; Mariana Pinteala; Volodymyr Brovarets; Sergii Slyvchuk; Stepan Pilyo; Athina Geronikaki; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

10.  The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors-A Spin-Off Discovery from Fragment Screening.

Authors:  Sarah L Mueller; Panagiotis K Chrysanthopoulos; Maria A Halili; Caryn Hepburn; Tom Nebl; Claudiu T Supuran; Alessio Nocentini; Thomas S Peat; Sally-Ann Poulsen
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.